2020
Gene variability in matrix metalloproteinases in patients with recurrent aphthous stomatitis
SLEZÁKOVÁ, Simona; Petra BOŘILOVÁ LINHARTOVÁ; Jirina BARTOVA; Jitka PETANOVA; Pavel KUKLINEK et al.Základní údaje
Originální název
Gene variability in matrix metalloproteinases in patients with recurrent aphthous stomatitis
Autoři
SLEZÁKOVÁ, Simona; Petra BOŘILOVÁ LINHARTOVÁ; Jirina BARTOVA; Jitka PETANOVA; Pavel KUKLINEK; Antonín FASSMANN; Ladislav DUŠEK a Lydie IZAKOVIČOVÁ HOLLÁ
Vydání
JOURNAL OF ORAL PATHOLOGY & MEDICINE, HOBOKEN, WILEY, 2020, 0904-2512
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30208 Dentistry, oral surgery and medicine
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.253
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/20:00115430
Organizační jednotka
Lékařská fakulta
UT WoS
000511596800001
EID Scopus
2-s2.0-85079161381
Klíčová slova anglicky
case-control study; matrix metalloproteinase; polymorphism; recurrent aphthous stomatitis
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2020 09:41, Mgr. Tereza Miškechová
Anotace
V originále
Background The development of recurrent aphthous stomatitis (RAS), inflammatory disease of oral mucosa, is influenced by both environmental and genetic factors. The aim of this study was to investigate polymorphisms located in seven genes coding different types of matrix metalloproteinases (MMPs)-collagenases (MMP1, MMP8, and MMP13), gelatinases (MMP2 and MMP9), stromelysin (MMP3), and membrane-type metalloproteinase (MMP16) in patients with RAS and healthy controls. Methods Totally, 223 subjects were included in this case-control study and their detailed anamnestic, clinical, and laboratory parameters were recorded. Seventy-seven patients with RAS and 146 controls were genotyped for seventeen polymorphisms in the MMPs genes using the real-time polymerase chain reaction (PCR) or PCR with restriction analysis. Results Allele, genotype, and haplotype frequencies of the studied polymorphisms between RAS patients and controls were similar, except for allele distributions of MMP1 rs1144393, MMP9 rs3918242, and MMP16 rs10429371, which were different between patients with RAS and healthy controls (P = .023, P = .049 and P = .025, all P-corr > 0.05, respectively). Moreover, the comparison of genotype frequencies (TT vs CC + CT) of the MMP16 rs10429371 variant showed a marginally significant difference between RAS patients and controls (P = .05, P-corr > 0.05, OR = 1.68, 95% CI = 0.95-2.98). Conclusions No significant relationship between investigated polymorphisms in seven MMPs genes and RAS development in the Czech population was observed in this study.
Návaznosti
| MUNI/A/1546/2018, interní kód MU |
|